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Contrast-Enhanced Ultrasound Examination for the Assessment of
Renal Perfusion in Cats with Chronic Kidney Disease
E. Stock , D. Paepe, S. Daminet, E. Vandermeulen, L. Duchateau, J.H. Saunders*, and
K. Vanderperren*
Background: Contrast-enhanced ultrasound examination (CEUS) is a functional imaging technique allowing noninvasive
assessment of tissue perfusion. Studies in humans show that the technique holds great potential to be used in the diagnosis of
chronic kidney disease (CKD). However, data in veterinary medicine are currently lacking.
Objectives: To evaluate renal perfusion using CEUS in cats with CKD.
Animals: Fourteen client-owned cats with CKD and 43 healthy control cats.
Methods: Prospective case-controlled clinical trial using CEUS to evaluate renal perfusion in cats with CKD compared to
healthy control cats. Time-intensity curves were created, and perfusion parameters were calculated using oﬀ-line software. A
linear mixed model was used to examine diﬀerences between perfusion parameters of cats with CKD and healthy cats.
Results: In cats with CKD, longer time to peak and shorter mean transit times were observed for the renal cortex. In con-
trast, a shorter time to peak and rise time were seen for the renal medulla. The findings for the renal cortex indicate
decreased blood velocity and shorter total duration of enhancement, likely caused by increased vascular resistance in CKD.
Increased blood velocity in the renal medulla has not been described before and may be because of a diﬀerent response to
regulatory factors in cortex and medulla.
Conclusions and Clinical Importance: Contrast-enhanced ultrasound examination was capable of detecting perfusion
changes in cats with CKD. Further research is warranted to assess the diagnostic capabilities of CEUS in early stage of the
disease process.
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Chronic kidney disease (CKD) is 1 of the most com-monly diagnosed diseases in cats. The prevalence
has been reported to be approximately 1–3% in the
general feline population, even increasing to 30% in
geriatric cats.1–3 Renal disease is reported to be the
cause of death in 14–17% of geriatric cats.4 A primary,
often unidentified trigger, initiates renal damage and
nephron loss, which ultimately results in self-perpetuat-
ing renal injury and progressive renal disease.5 The
most common histologic findings in cats with CKD are
tubulointerstitial lesions such as tubular atrophy, inter-
stitial inflammation, and fibrosis.6 Diagnosis at an early
stage of the disease progress allows timely institution of
supportive treatment and slows the disease progress.7
Prompt diagnosis remains challenging. The diagnosis
most often is based on increases in serum urea and cre-
atinine concentrations combined with low urine specific
gravity. These changes unfortunately are only present
when a substantial portion of renal function already
has been lost. Measurement of glomerular filtration rate
(GFR) provides more accurate assessment of renal
function, but requires multiple blood samples, limiting
its use in routine clinical practice.8,9 Therefore, the
search for improved noninvasive methods for the diag-
nosis of early renal disease is still ongoing.
Renal function is closely related to renal perfusion.
Therefore, evaluation of renal perfusion could yield
valuable information about kidney function and thus
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PE peak enhancement
ROI region of interest
RT rise time
sCr serum creatinine
TTP time to peak
UPC urinary protein:creatinine ratio
USG urine specific gravity
WiAUC wash-in area under the curve
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Standard Article
J Vet Intern Med 2017
facilitate earlier diagnosis. Performing an accurate and
noninvasive measurement of renal perfusion is challeng-
ing. Dynamic high-field magnetic resonance imaging,
contrast-enhanced computed tomography, or renal
scintigraphy can be used to assess renal perfusion. In
practice, clinical application of these techniques is limited
by relatively high costs, limited availability, long exami-
nation times, and exposure to ionizing radiation.10,11
Doppler ultrasound examination allows calculation of
perfusion indices that provide information about vascu-
lar resistance. These indices are increased in animals with
renal disease, but are relatively nonspecific because they
are influenced by several nonrenal factors.12–14 More-
over, Doppler ultrasound examination is limited to evalu-
ation of macroperfusion because low-velocity flow in
smaller vessels cannot be assessed.12
Contrast-enhanced ultrasound examination (CEUS)
is a functional imaging technique using microbubbles to
enhance detection of tissue perfusion at the microvascu-
lar level. These bubbles are gas-filled spheres stabilized
by an outer shell. They have a size similar to that of
red blood cells and thus are restricted to the blood pool
after IV injection. In cats, the literature currently is lim-
ited to the description of the normal perfusion pattern
in healthy animals.15–17 In dogs, the perfusion pattern
of focal mass lesions has been described, and quantita-
tive CEUS in dogs with iatrogenically-induced hyper-
cortisolism and ischemic renal disease has been
described.18–20 Lower blood velocity was found in the
dogs with ischemic renal disease, whereas an increase in
renal blood volume was seen in dogs with hyper-
cortisolism.19,20 Contrast-enhanced ultrasound examina-
tion has been shown to be a promising technique for
the early diagnosis of renal disease in humans, but data
on cats with renal disease are currently lacking.21,22
Our aim was to evaluate the eﬃcacy of CEUS in the
diagnosis of CKD in cats. Our hypothesis was that
CEUS would be a practical, noninvasive technique to
detect perfusion changes in cats with CKD.
Materials and Methods
The study was performed with approval of the local ethical
committee of the Faculty of Veterinary Medicine, Ghent Univer-
sity, Belgium and the deontological committee of the Belgian Fed-
eral Agency for the Safety of the Food Chain (EC2015-68). All
owners gave their full informed consent to participate in the study.
Subjects
Fourteen client-owned cats with CKD and 43 healthy control
cats were included. The diagnosis of CKD was made before inclu-
sion and was based on the presence of compatible clinical signs
and laboratory findings such as increased serum creatinine concen-
tration (>161.8 lmol/L)23 and decreased urine specific gravity
(<1.035). Cats with clinically relevant concurrent systemic disease,
hyperthyroidism, or urinary tract obstructions leading to postrenal
azotemia were excluded. The cats with CKD were subdivided into
4 groups according to the classification of the International Renal
Interest Society (IRIS).24 Cats without clinically relevant abnor-
malities in history, on physical examination, thoracic radiographs,
routine abdominal ultrasound examination, CBC, serum
biochemistry, and urinalysis were considered healthy. All medica-
tion or nutritional supplements, except for phosphorous binders in
the CKD group, were withdrawn at least 14 days before inclusion.
Study Design
A thorough physical examination, including noninvasive mea-
surement of blood pressure by Doppler ultrasonic technique and
cervical palpation for scoring thyroid gland size (in cats >6 years),
was performed.25 Blood testing consisted of CBC and serum bio-
chemistry, including total thyroxine (TT4) serum concentration in
cats >6 years of age. Urinalysis included urine specific gravity
(USG), sediment analysis (as previously described),26 urinary pro-
tein/creatinine ratio (UPC), dipstick chemistry, and urine culture.
Thoracic radiographs (left-to-right lateral and ventrodorsal
projections) and complete abdominal ultrasound examination were
performed.
CEUS Procedure
A 22-gauge indwelling catheter was placed in the cephalic vein.
The hair was clipped over the ventrolateral portion of the abdo-
men and coupling gel was applied to the skin. The ultrasound
examinations were performed with the cat manually restrained in
dorsal recumbency. The kidney of interest was centered on the
screen and was imaged in a longitudinal plane using dual-screen
(simultaneous display of conventional B-mode and contrast-mode
images). The transducer was manually positioned during each
imaging procedure and was maintained at the same position
during CEUS.
The contrast agent,a 0.05 mL/kg, was injected IV (bolus injec-
tion over approximately 3 seconds) followed by injection of a
1.5 mL saline bolus. A 3-way stopcock was used to avoid any
delay between injection of contrast agent and saline. The same
person performed the injection in a standardized way in all cats.
Three injections of contrast were performed: 2 for the left kidney
and 1 for the right kidney. The first injection was not used for fur-
ther analysis, because it results in lower enhancement compared to
the second and third injection.27 Between subsequent injections, to
avoid artifacts, remnant microbubbles were completely destroyed
by setting the acoustic power at the highest level and scanning
the caudal aspect of the abdominal aorta for approximately
2 minutes.
All examinations were performed using a linear transducer of
12–5 MHz on a dedicated machineb with contrast-specific soft-
ware. Basic technical parameters were a single focus placed under
the kidney, persistency oﬀ, mechanical index 0.09, high dynamic
range setting (C50), timer started at the beginning of the injection,
gain (85%, corresponding to a nearly dark/anechoic image before
contrast agent administration). The settings were repeated during
each injection. All studies were digitally registered as a movie clip
at a rate of 9 frames per second, for 90 seconds.
The clips were analyzed using specialized computer softwarec
for objective quantitative analysis. Six regions-of-interest (ROIs)
were manually drawn: 3 in the renal cortex, 2 in the renal medulla,
and 1 on an interlobar artery. The ROIs were similar in size and
drawn at the same depth for every region. For every ROI, the
software determined mean pixel intensity and created a time-inten-
sity curve. Time-intensity curves were analyzed for peak enhance-
ment (PE), wash-in area under the curve (WiAUC), rise time
(RT), mean transit time (mTT), time to peak (TTP), wash-in rate
(WiR), wash-in perfusion index (WiPI; WiAUC/RT), wash-out
area under the curve (WoAUC), total area under the curve
(AUC), fall time (FT), and wash-out rate (WoR). Parameters
related to blood volume are PE, WiAUC, WoAUC, and AUC.
The PE corresponds to the maximum contrast medium signal
2 Stock et al
intensity. The WiAUC is calculated as the sum of all amplitudes
inside the range from the beginning of the curve up to the TTP.
Similarly, WoAUC corresponds to the sum of all amplitudes inside
the range from the TTP to the end of the descending curve. The
other parameters (i.e., RT, mTT, TTP, WiR, WiPI, FT, WoR),
are related to blood velocity. The WiR and WoR represent the
maximum and minimum slopes of time-intensity curve. The RT
corresponds to the time interval between the first arrival of con-
trast and the time of peak intensity. The FT, on the other hand, is
the duration of contrast wash-out. Mean transit time is the mean
duration of complete contrast medium perfusion. The perfusion
parameters are illustrated in Figure 1. The values for the 3 ROIs
in the renal cortex and the 2 ROIs in the renal medulla were aver-
aged. Peak enhancement and WiAUC for the cortex and medulla
were normalized to the values obtained for the interlobar artery.
Statistical Analysis
Statistical analyses were performed using statistical software.d A
linear mixed model with cat as random eﬀect and health status
(CKD/healthy) as categorical fixed eﬀect was used. Age group also
was incorporated in the model as a categorical fixed eﬀect to
adjust for age between CKD and healthy cats. Age groups were
defined as: group 1 (1–3 years), group 2 (3–6 years), group 3 (6–
10 years), and group 4 (>10 years). Correlations between perfusion
parameters and renal size, IRIS stage, serum creatinine concentra-
tion (sCr), USG, and UPC were calculated for the renal cortex
and medulla using Spearman correlation coeﬃcients (q). A diﬀer-
ence was considered statistically significant if P < 0.05.
Results
Breed distribution consisted of 9 domestic short- or
long-haired cats and 5 pure-bred cats (2 Ragdoll cats, 2
Bengals, and 1 British Shorthair) for the group of cats
with CKD and 41 domestic short- or long-haired cats
and 2 pure-bred cats (2 Ragdoll cats) for the healthy
cats. The mean ! standard deviation age for the CKD
group was 9.3 ! 5.2 years, and 6.5 ! 3.9 years for the
healthy group. The mean ! standard deviation body
weight for the CKD group was 4.2 ! 1.1 kg, and for
the healthy group 4.0 ! 0.7 kg. Six cats had IRIS stage
2 CKD, 1 of them was proteinuric (UPC > 0.4). Eight
cats had IRIS stage 3 CKD, of which 2 cats had
proteinuria.
Systolic blood pressure, sCr, serum urea concentra-
tion, USG, and UPC are summarized in Table 1.
All healthy cats had normal size and appearance of
their kidneys on B-mode ultrasonography. For the
CKD group, renal size was <3.0 cm for 1 or both kid-
neys in 6 cats, 7 cats had segmental cortical lesions in 1
or both kidneys, an irregular outline for 1 of both kid-
neys was observed in 10 cats, and corticomedullary defi-
nition was decreased in all cats. One cat had mild
unilateral pyelectasia, and another cat had mild bilat-
eral pyelectasia, without signs of ureteral obstruction. A
single large cyst deforming the renal cortex was present
in 1 cat, whereas few small cortical cystic lesions were
detected in both kidneys in another, domestic short-
haired cat. None of the cats was diagnosed with poly-
cystic kidney disease.
The contrast agent and the imaging procedure were
well tolerated by all cats and no adverse eﬀects were
noticed.
Qualitative analysis of the CEUS images showed
heterogeneous cortical enhancement in all cats with seg-
mental cortical lesions (Fig 2).
Quantitative CEUS showed significant diﬀerences
between CKD and healthy cats in several perfusion
parameters for the renal cortex and medulla (Table 2
and Fig 2). The mTT for the renal cortex, a parameter
for mean duration of complete contrast medium perfu-
sion, was approximately 4 seconds shorter in cats with
CKD compared to healthy cats (P = 0.028). The TTP
for the cortex was longer in the CKD group
(P = 0.003). In contrast, for the medulla, the TTP
decreased for the cats with CKD (P = 0.003), associated
with a shorter RT (P = 0.001) and FT (P = 0.04)
(Figs 3 and 4).
For the renal cortex and medulla, significant correla-
tions were present between the mTT and TTP and IRIS
stage, and renal size. Additionally, significant correla-
tions were identified between the RT for the renal
medulla and sCr, IRIS stage, USG, and renal size. For
the renal medulla, mTT and TPP also were significantly
correlated to sCr, USG, and renal size. Urine specific
gravity was significantly correlated to medullary RT,
mTT and TTP and to cortical peak enhancement
Fig 1. Typical time-intensity curve obtained after bolus injection
of ultrasound contrast agent, illustration of the perfusion parame-
ters. Time in second (s) is displayed on the horizontal axis and the
intensity in arbitrary units (au) on the vertical axis.
Table 1. Baseline characteristics for CKD and healthy





(n = 14) P-value
Blood pressure
(mmHg)
144.3 ! 13.5 141.0 ! 38.7 0.632
sCr (lmol/L) 110.4 ! 19.5* 278.1 ! 61.0* <0.001
Serum urea
(mmol/L)
8.2 ! 1.5* 18.8 ! 4.6* <0.001
USG 1.048 ! 0.004* 1.021 ! 0.013* <0.001
UPC 0.13 ! 0.11* 0.34 ! 0.33* 0.004
sCr, serum creatinine concentrations; USG, urine specific grav-
ity; UPC, urinary protein:creatinine ratio. *significant diﬀerence.
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normalized to the interlobar artery. Additionally, a
significant correlation was present for the cortical PE*
and IRIS stage. Spearman correlation coeﬃcients and
P-values are summarized in Tables 3 and 4.
Discussion
Histologic studies in human and rodent kidneys have
shown that tubulointerstitial lesions are associated with
damage to the renal arterioles and arteries, and distor-
tion and loss of peritubular capillaries.28 Tubulointersti-
tial fibrosis impairs renal blood flow and increases renal
vascular resistance.28,29 Renal capillary rarefaction is
considered a central mechanism in initiation and pro-
gression of CKD in people and rodents.30,31 Moreover,
the renin-angiotensin system is activated in CKD lead-
ing to higher renal tissue concentrations of angiotensin
II compared to plasma concentrations. Because angio-
tensin II is a potent vasoconstrictor, the combination of
these changes is likely to decrease renal blood flow in
patients with CKD, resulting in decreased blood volume
and velocity. A recent study using computed tomogra-
phy angiography to evaluate renal blood volume and
vascular anatomy in people showed a 41% decrease in
renal cortical blood volume in patients with CKD com-
pared to healthy subjects. The patients with CKD also
had decreased luminal diameters of segmental arteries.
Moreover, cortical renal blood volume decreased during
progression of CKD and was correlated with a decrease
in GFR.31 Medullary blood volume was more variable
and did not correlate with GFR.31
The most striking findings of our study were shorter
mTT time, indicating shorter enhancement, and
increased TTP in the renal cortex. The longer TTP sug-
gests decreased blood velocity. These findings corre-
spond to previous studies in human medicine, in which
decreased TTP also was described in patients with
CKD of various origin and in patients with diabetic
nephropathy.32,33 Decreased TTP also was an early
finding in dogs in which ischemic renal disease was
induced by placing an ameroid constrictor around the
renal artery.20
The PE, a parameter for the intensity of enhance-
ment, reflects the blood volume entering the kidney and
hence is expected to be decreased in patients with
CKD. Previous studies using CEUS in humans with
CKD reported a decrease in PE21,22,32,33; however, a
significant decrease in PE was not identified in our
study. Nevertheless, close inspection of the results in
these studies shows that a great degree of overlap in PE
is present for patients with CKD and healthy
subjects.21,22,32,33 Relatively few patients with CKD
were included in our study and larger numbers of cats
are needed to determine if significance can be achieved.
Moreover, PE is known to suﬀer from inherently high
variability, because it is susceptible to many influencing
factors.34,35 Variation may be attributed to the contrast
agent itself (amount and physical properties of the
Fig 2. Representative serial contrast ultrasound images in a healthy cat (right) and a cat suﬀering from chronic kidney disease (left). The
arrival of contrast agent in the renal cortex is delayed in cats with CKD; moreover, the duration of enhancement is shorter compared to
healthy cats.
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microbubbles), uncontrollable patient factors such as
blood pressure, heart rate, filtration of the bubbles by
the lungs, phagocytosis of bubbles by the reticuloen-
dothelial system, and the manual injection procedure
itself. Using controlled injection systems or continuous
infusion of contrast agent, followed by flash-replenish-
ment kinetics may improve the diagnostic accuracy of
the technique.34,35
Table 2. Mean ! standard deviation values of renal
perfusion parameters for cats suﬀering from CKD and
healthy cats.
Variable, by
location CKD Healthy P-value
Renal cortex
PE 1635.12 ! 1008.71 1779.16 ! 991.75 0.643
PE* 19.24 ! 14.82 27.72 ! 13.18 0.065
WiAUC 2751.49 ! 1442.52 2869.57 ! 1418.18 0.791
RT 3.01 ! 0.45 2.77 ! 0.39 0.068
mTT 17.63 ! 6.06 21.84 ! 5.97 0.028
TTP 8.75 ! 1.09 7.71 ! 1.05 0.003
WiR 800.61 ! 605.85 904.15 ! 595.68 0.580
WiPI 1000.53 ! 615.84 1089.36 ! 605.45 0.640
WoAUC 3606.29 ! 1824.25 3830.47 ! 1793.46 0.690
AUC 6357.95 ! 3262.09 6700.00 ! 3207.05 0.733
FT 4.12 ! 0.75 3.83 ! 0.72 0.199
WoR 523.94 ! 444.40 638.30 ! 437.05 0.405
Renal medulla
PE 208.71 ! 762.21 276.83 ! 649.58 0.766
PE* 3.65 ! 2.62 3.02 ! 2.36 0.433
WiAUC 1653.36 ! 1307.00 1892.97 ! 1133.85 0.542
RT 11.23 ! 5.43 16.69 ! 4.66 0.001
mTT 50.48 ! 105.29 111.03 ! 91.08 0.060
TTP 20.16 ! 6.21 27.37 ! 5.38 0.003
WiR 4.69 ! 648.95 93.23 ! 552.73 0.649
WiPI 130.85 ! 466.66 172.68 ! 397.51 0.765
WoAUC 2934.74 ! 1979.94 3519.01 ! 1970.38 0.387
AUC 4570.11 ! 3449.17 5446.80 ! 3065.60 0.404
FT 23.25 ! 14.07 32.05 ! 12.46 0.043
WoR 0.00 ! 528.36 70.26 ! 462.17 0.631
PE, peak enhancement; PE* normalized PE; WiAUC, wash-in
area under the curve; RT, rise time; mTT, mean transit time; TTP,
time to peak; WiR, wash-in rate; WiPI, wash-in perfusion index;
WoAUC, wash-out area under the curve; AUC, total area under
the curve; FT, fall time; WoR, wash-out rate. Values in bold
represent significant diﬀerences between CKD and healthy cats.
Fig 3. Mean time-intensity curves calculated for the renal cortex
of healthy cats (orange) and cats with CKD (green) for the first 15
seconds after contrast injection, illustrating a delayed time to peak
and a shorter mean transit time in cats suﬀering from CKD. The
time in seconds (s) is displayed on the horizontal axis, the intensity
in arbitrary units (au) on the vertical axis.
Fig 4. Mean time-intensity curves calculated for the renal
medulla of healthy cats (orange) and cats with CKD (green) dur-
ing 90 seconds after contrast injection, illustrating a shorter time
to peak and short rise time for cats suﬀering from CKD. The time
in seconds (s) is displayed on the horizontal axis, the intensity in
arbitrary units (au) on the vertical axis.
Table 3. Correlations between IRIS stage, renal size,
USG, and renal perfusion parameters for the renal cor-
tex.
Variable pair q (P)
IRIS stage – mTT "0.29 (0.03)
IRIS stage – TTP 0.32 (0.02)
IRIS stage – PE* "0.37 (0.005)
Renal size – mTT 0.30 (0.02)
Renal size –TTP "0.30 (0.02)
USG – PE* 0.10 (0.43)
Table 4. Correlations between IRIS stage, renal size,
USG, and renal perfusion parameters for the renal
medulla.
Correlation q (P)
sCr – mTT "0.38 (0.004)
sCr – TTP "0.43 (0.001)
sCr – RT "0.46 (0.003)
IRIS stage – mTT "0.38 (0.005)
IRIS stage – TTP "0.47 (0.003)
IRIS stage – RT "0.41 (0.002)
Renal size – mTT 0.43 (0.001)
Renal size –TTP 0.33 (0.01)
Renal size – RT 0.41 (0.001)
USG –mTT 0.45 (0.005)
USG – TTP 0.37 (0.006)
USG – RT 0.31 (0.02)
Changes in AUC also have been described in humans
with CKD, whereas no significance was obtained in our
study. Both an increase and a decrease in AUC have
been described in people with CKD. An increase in
AUC was observed in early stage diabetic nephropathy,
whereas a decrease was noticed in advanced stages.33
An increase in AUC was reported in 41 humans with
CKD, whereas a decrease was reported in a study of
dogs with iatrogenic ischemic renal disease.20,21 The
variable eﬀects on AUC may be explained by the fact
that AUC is influenced by PE, as well as the slope of
the time-intensity curve. The AUC actually is composed
of 2 parts: an initial part relating to inflow of contrast
and a descending part related to the outflow of contrast
medium. Moreover, AUC may be influenced by the
stage and progression of CKD.
The decreased TTP and RT for the renal medulla in
patients with CKD in our study were not completely
expected. Only 1 study has described CEUS of the
medulla in people with CKD. In the study of humans,
findings for the medulla parallelled those of the cortex,
showing delayed time to peak.32 Still, the vascular anat-
omy and physiology of the renal medulla diﬀer substan-
tially from those of the cortex. The renal medulla
makes up <30% of the total renal volume but only
receives 10% of the total renal blood flow. Addition-
ally, local diﬀerences are described for the outer and
inner medulla, with the latter being less perfused.
Vasoactive regulatory factors have diﬀerent eﬀects on
cortical and medullary blood flow. The medulla is rela-
tive insensitive to vasoconstriction.36 Therefore, locally
increased blood velocity could be present in the medulla
in cats with CKD. However, additional studies are
needed to confirm this finding and further investigate
the underlying pathophysiology.
We found significant correlations between time-based
perfusion parameters and sCr, IRIS stage, USG, UPC,
and renal size. However, correlation coeﬃcients were
low and did not exceed 0.50 in most cases. The highest
correlation coeﬃcient was observed for UPC and TTP
for the renal medulla. Similarly low, but significant cor-
relation coeﬃcients are described in 2 studies of
humans. Correlation coeﬃcients of 0.26–0.40 between
the slope of the ascending and descending parts of the
time-intensity curve and sCr-based estimated GFR have
been observed.32 Additionally, a significant correlation
was present between PE and estimated GFR
(r = 0.27).32 Similarly, a correlation (r = 0.47) between
AUC and GFR measured by radionuclide clearance
techniques has been described in people with diabetic
nephropathy.33 Moreover, the correlations calculated in
our study of cats are based on a small number of ani-
mals and therefore should be interpreted with caution.
The IRIS staging system is routinely used to facilitate
monitoring, treatment, and estimating prognosis in dogs
and cats with CKD. We investigated if diﬀerences in
CEUS parameters could be identified among diﬀerent
IRIS stages. As described above, this goal was limited
by the low number of cats. The severity of tubular
degeneration, interstitial inflammation, fibrosis, and
glomerulosclerosis was significantly greater in later
stages compared to earlier stages of CKD in cats.37
We determined CEUS perfusion parameters in a
large population of healthy cats. Previous studies per-
forming CEUS in healthy cats only included small
numbers of cats (8–10); moreover, only young cats
were included. Additionally, sedation, anesthesia, or
both were used in these studies, likely influencing renal
perfusion.15–17 In addition to these issues, comparison
of perfusion variables among studies is not possible
because the injection procedure, contrast agent,
machine settings, and software all influence the type of
perfusion parameters calculated and their values. Time
to peak is the most consistently calculated parameter
in CEUS studies. The TTP in our study is in the same
range as the TTP described in 1 study of cats,17
whereas is it substantially shorter compared to the
results in another study of cats.16 Time to peak is lar-
gely influenced by the injection procedure and the
sedation or anesthesia used.
In conclusion, our findings in a small cohort of cats
with CKD are encouraging with respect to the use of
CEUS to evaluate renal perfusion in cats. A decrease in
blood velocity was detected for the renal cortex whereas
increased blood velocity was present in the renal
medulla. The enhancement of the renal cortex was
found to be of shorter duration in cats with CKD (de-
creased mTT). However, no significant changes could
be detected in parameters representing the blood vol-
ume. Additional studies are necessary to evaluate the
added value of CEUS in the diagnosis of early, nona-
zotemic CKD in cats.
Footnotes
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